Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BNTX
BNTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BNTX News
First PD-(L)1xVEGF Bispecific Immunomodulator Shows Promising Efficacy in NSCLC
6h ago
Newsfilter
Wall Street's Latest Rating Changes Overview
3d ago
CNBC
BioNTech's Promising Clinical Data for Pumitamig and Gotistobart at ASCO 2026
May 22 2026
Newsfilter
BioNTech Annual General Meeting Approves Key Resolutions
May 15 2026
Newsfilter
Hantavirus Outbreak Sparks Rally in Biotech Stocks
May 13 2026
Fool
Bristol Myers Squibb Faces Patent Cliff Challenges
May 12 2026
Fool
Bristol Myers Squibb Faces Patent Cliffs Ahead
May 12 2026
NASDAQ.COM
BioNTech Q1 2026 Earnings Call Insights
May 05 2026
seekingalpha
BioNTech to Lay Off 1,860 Employees, Shift Focus to Oncology
May 05 2026
seekingalpha
BioNTech Reports Wider Q1 Net Loss Amid Revenue Decline
May 05 2026
NASDAQ.COM
BioNTech Reaffirms 2026 Financial Guidance Amid Q1 Loss
May 05 2026
seekingalpha
BioNTech Scheduled to Announce Q1 Earnings on May 5
May 04 2026
seekingalpha
Netflix Authorizes $25 Billion Buyback Program to Boost Shareholder Confidence
Apr 23 2026
Fool
Analysis of Investment Prospects in Healthcare Stocks
Apr 15 2026
Fool
BioNTech Reports Phase 2 Results for HER2 Cancer Drug
Apr 13 2026
NASDAQ.COM
Trastuzumab Pamirtecan Shows Promising Results in Endometrial Cancer Clinical Trial
Apr 11 2026
Newsfilter
Show More News
